Stuttgart - Delayed Quote • EUR
Nektar Therapeutics (ITH.SG)
At close: April 26 at 10:32 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-192,606.0000
-192,606.0000
-304,007.0000
-412,660.0000
-313,287.0000
Investing Cash Flow
139,564.0000
139,564.0000
365,835.0000
202,777.0000
496,213.0000
Financing Cash Flow
30.0000
30.0000
1,508.0000
36,238.0000
-80,354.0000
End Cash Position
35,277.0000
35,277.0000
88,227.0000
25,218.0000
198,955.0000
Income Tax Paid Supplemental Data
2,656.0000
2,656.0000
272.0000
325.0000
539.0000
Interest Paid Supplemental Data
--
--
--
--
9,742.0000
Capital Expenditure
-865.0000
-865.0000
-5,676.0000
-14,989.0000
-7,258.0000
Issuance of Debt
--
--
--
--
146,250.0000
Repayment of Debt
--
--
--
--
-250,000.0000
Free Cash Flow
-193,471.0000
-193,471.0000
-309,683.0000
-427,649.0000
-320,545.0000
12/31/2020 - 4/10/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
3.9250
+2.75%
FBLG FibroBiologics, Inc.
10.11
-13.44%
ANRO Alto Neuroscience, Inc.
14.18
+0.35%
PHRM.CN PharmaTher Holdings Ltd.
0.2400
-2.04%
TRVI Trevi Therapeutics, Inc.
2.7800
+9.45%
CYCC Cyclacel Pharmaceuticals, Inc.
1.5100
-5.63%
ACXP Acurx Pharmaceuticals, Inc.
2.0700
+2.48%
PMVP PMV Pharmaceuticals, Inc.
1.7500
+2.34%
GOVX GeoVax Labs, Inc.
1.4200
-3.40%
TCRX TScan Therapeutics, Inc.
7.32
+0.41%